Ubiquitin-proteasome system impairment and MPTP-induced oxidative stress in the brain of C57BL/6 wild-type and GSTP knockout mice.

Molecular neurobiology

Volumn 47, Issue 2, 2013, Pages 662-672

  Carvalho, Andreia Neves ^a   Marques, Carla ^b   Rodrigues, Elsa ^b   Henderson, Colin J ^b   Wolf, C Roland ^b   Pereira, Paulo ^b   Gama, Maria João ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLUTATHIONE TRANSFERASE P1; PROTEASOME; UBIQUITIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PROTEIN UNFOLDING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; GLUTATHIONE S-TRANSFERASE PI; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN UNFOLDING; UBIQUITIN;

EID: 84886087240     PISSN: None     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8368-4     Document Type: Article

References (48)

1. 1. A Ciechanover P Brundin 2003 The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg Neuron 40 2 427 446 14556719 10.1016/S0896-6273(03)00606-8 1:CAS:528:DC%2BD3sXosFCqs70%3D Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40(2):427–446
2. 2. AL Schwartz A Ciechanover 2009 Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology Annu Rev Pharmacol Toxicol 49 73 96 18834306 10.1146/annurev.pharmtox.051208.165340 1:CAS:528:DC%2BD1MXisV2jsLw%3D Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49:73–96
3. 3. MH Glickman A Ciechanover 2002 The ubiquitin–proteasome proteolytic pathway: destruction for the sake of construction Physiol Rev 82 2 373 428 11917093 1:CAS:528:DC%2BD38XjtFOnsL4%3D Glickman MH, Ciechanover A (2002) The ubiquitin–proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82(2):373–428
4. 4. AL Haas IA Rose 1982 The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis J Biol Chem 257 17 10329 10337 6286650 1:CAS:528:DyaL3sXmslygsA%3D%3D Haas AL, Rose IA (1982) The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. J Biol Chem 257(17):10329–10337
5. 5. AL Haas JV Warms A Hershko IA Rose 1982 Ubiquitin-activating enzyme. Mechanism and role in protein–ubiquitin conjugation J Biol Chem 257 5 2543 2548 6277905 1:CAS:528:DyaL38Xhtlyrsrg%3D Haas AL, Warms JV, Hershko A, Rose IA (1982) Ubiquitin-activating enzyme. Mechanism and role in protein–ubiquitin conjugation. J Biol Chem 257(5):2543–2548
6. 6. CM Pickart IA Rose 1985 Functional heterogeneity of ubiquitin carrier proteins J Biol Chem 260 3 1573 1581 2981864 1:CAS:528:DyaL2MXpt1Sisg%3D%3D Pickart CM, Rose IA (1985) Functional heterogeneity of ubiquitin carrier proteins. J Biol Chem 260(3):1573–1581
7. 7. AL Haas PM Bright 1988 The resolution and characterization of putative ubiquitin carrier protein isozymes from rabbit reticulocytes J Biol Chem 263 26 13258 13267 3417657 1:CAS:528:DyaL1MXntFGntA%3D%3D Haas AL, Bright PM (1988) The resolution and characterization of putative ubiquitin carrier protein isozymes from rabbit reticulocytes. J Biol Chem 263(26):13258–13267
8. 8. A Hershko H Heller S Elias A Ciechanover 1983 Components of ubiquitin–protein ligase system. Resolution, affinity purification, and role in protein breakdown J Biol Chem 258 13 8206 8214 6305978 1:CAS:528:DyaL3sXksV2nsLc%3D Hershko A, Heller H, Elias S, Ciechanover A (1983) Components of ubiquitin–protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem 258(13):8206–8214
9. 9. JP Taylor J Hardy KH Fischbeck 2002 Toxic proteins in neurodegenerative disease Science (New York, NY) 296 5575 1991 1995 10.1126/science.1067122 1:CAS:528:DC%2BD38Xks1ehsrw%3D Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science (New York, NY) 296(5575):1991–1995
10. 10. W Dauer S Przedborski 2003 Parkinson's disease: mechanisms and models Neuron 39 6 889 909 12971891 10.1016/S0896-6273(03)00568-3 1:CAS:528:DC%2BD3sXnsFait7o%3D Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39(6):889–909
11. 11. DJ Moore AB West VL Dawson TM Dawson 2005 Molecular pathophysiology of Parkinson's disease Annu Rev Neurosci 28 57 87 16022590 10.1146/annurev.neuro.28.061604.135718 1:CAS:528:DC%2BD2MXosVegt7c%3D Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28:57–87
12. 12. KS McNaught P Jenner 2001 Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci Lett 297 3 191 194 11137760 10.1016/S0304-3940(00)01701-8 1:CAS:528:DC%2BD3MXhsFejsb0%3D McNaught KS, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett 297(3):191–194
13. 13. TM Dawson VL Dawson 2003 Rare genetic mutations shed light on the pathogenesis of Parkinson disease J Clin Investig 111 2 145 151 12531866 1:CAS:528:DC%2BD3sXlsVGktQ%3D%3D Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Investig 111(2):145–151
14. 14. CW Olanow KS McNaught 2006 Ubiquitin–proteasome system and Parkinson's disease Mov Disord 21 11 1806 1823 16972273 10.1002/mds.21013 Olanow CW, McNaught KS (2006) Ubiquitin–proteasome system and Parkinson's disease. Mov Disord 21(11):1806–1823
15. 15. KS McNaught R Jnobaptiste T Jackson TA Jengelley 2010 The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease Synapse (New York, NY) 64 3 241 250 10.1002/syn.20719 1:CAS:528:DC%2BC3cXkvFKjug%3D%3D McNaught KS, Jnobaptiste R, Jackson T, Jengelley TA (2010) The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease. Synapse (New York, NY) 64(3):241–250
16. 16. T Kitada S Asakawa N Hattori H Matsumine Y Yamamura S Minoshima M Yokochi Y Mizuno N Shimizu 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 6676 605 608 9560156 10.1038/33416 1:CAS:528:DyaK1cXis1Sqsrc%3D Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605–608
17. 17. E Leroy R Boyer G Auburger B Leube G Ulm E Mezey G Harta MJ Brownstein S Jonnalagada T Chernova A Dehejia C Lavedan T Gasser PJ Steinbach KD Wilkinson MH Polymeropoulos 1998 The ubiquitin pathway in Parkinson's disease Nature 395 6701 451 452 9774100 10.1038/26652 1:CAS:528:DyaK1cXms1antLo%3D Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson's disease. Nature 395(6701):451–452
18. 18. Y Furukawa S Vigouroux H Wong M Guttman AH Rajput L Ang M Briand SJ Kish Y Briand 2002 Brain proteasomal function in sporadic Parkinson's disease and related disorders Ann Neurol 51 6 779 782 12112087 10.1002/ana.10207 Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y (2002) Brain proteasomal function in sporadic Parkinson's disease and related disorders. Ann Neurol 51(6):779–782
19. 19. KS McNaught DP Perl AL Brownell CW Olanow 2004 Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease Ann Neurol 56 1 149 162 15236415 10.1002/ana.20186 1:CAS:528:DC%2BD2cXmsVSns7c%3D McNaught KS, Perl DP, Brownell AL, Olanow CW (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 56(1):149–162
20. 20. EH Yew NS Cheung MS Choy RZ Qi AY Lee ZF Peng AJ Melendez J Manikandan ES Koay LL Chiu WL Ng M Whiteman J Kandiah B Halliwell 2005 Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis J Neurochem 94 4 943 956 15992382 10.1111/j.1471-4159.2005.03220.x 1:CAS:528:DC%2BD2MXpsFCltr0%3D Yew EH, Cheung NS, Choy MS, Qi RZ, Lee AY, Peng ZF, Melendez AJ, Manikandan J, Koay ES, Chiu LL, Ng WL, Whiteman M, Kandiah J, Halliwell B (2005) Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis. J Neurochem 94(4):943–956
21. 21. M Inden J Kondo Y Kitamura K Takata K Nishimura T Taniguchi H Sawada S Shimohama 2005 Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats J Pharmacol Sci 97 2 203 211 15684568 10.1254/jphs.FP0040525 1:CAS:528:DC%2BD2MXhvFKlsbk%3D Inden M, Kondo J, Kitamura Y, Takata K, Nishimura K, Taniguchi T, Sawada H, Shimohama S (2005) Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats. J Pharmacol Sci 97(2):203–211
22. 22. H Sawada R Kohno T Kihara Y Izumi N Sakka M Ibi M Nakanishi T Nakamizo K Yamakawa H Shibasaki N Yamamoto A Akaike M Inden Y Kitamura T Taniguchi S Shimohama 2004 Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions J Biol Chem 279 11 10710 10719 14672949 10.1074/jbc.M308434200 1:CAS:528:DC%2BD2cXhvFChtrw%3D Sawada H, Kohno R, Kihara T, Izumi Y, Sakka N, Ibi M, Nakanishi M, Nakamizo T, Yamakawa K, Shibasaki H, Yamamoto N, Akaike A, Inden M, Kitamura Y, Taniguchi T, Shimohama S (2004) Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. J Biol Chem 279(11):10710–10719
23. 23. BN Mathur MD Neely M Dyllick-Brenzinger A Tandon AY Deutch 2007 Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration Brain Res 1168 83 89 17706185 10.1016/j.brainres.2007.06.076 1:CAS:528:DC%2BD2sXpvFKhtbo%3D Mathur BN, Neely MD, Dyllick-Brenzinger M, Tandon A, Deutch AY (2007) Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration. Brain Res 1168:83–89
24. 24. F Fornai OM Schluter P Lenzi M Gesi R Ruffoli M Ferrucci G Lazzeri CL Busceti F Pontarelli G Battaglia A Pellegrini F Nicoletti S Ruggieri A Paparelli TC Sudhof 2005 Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin–proteasome system and alpha-synuclein Proc Natl Acad Sci U S A 102 9 3413 3418 15716361 10.1073/pnas.0409713102 1:CAS:528:DC%2BD2MXitl2lu74%3D Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin–proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102(9):3413–3418
25. 25. F Fornai P Lenzi M Gesi M Ferrucci G Lazzeri CL Busceti R Ruffoli P Soldani S Ruggieri MG Alessandri A Paparelli 2003 Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition J Neurosci 23 26 8955 8966 14523098 1:CAS:528:DC%2BD3sXotFOnurY%3D Fornai F, Lenzi P, Gesi M, Ferrucci M, Lazzeri G, Busceti CL, Ruffoli R, Soldani P, Ruggieri S, Alessandri MG, Paparelli A (2003) Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition. J Neurosci 23(26):8955–8966
26. 26. CJ Henderson AW McLaren GJ Moffat EJ Bacon CR Wolf 1998 Pi-class glutathione S-transferase: regulation and function Chem Biol Interact 111–112 69 82 9679544 10.1016/S0009-2797(97)00176-2 Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, Wolf CR (1998) Pi-class glutathione S-transferase: regulation and function. Chem Biol Interact 111–112:69–82
27. 27. JD Hayes JU Flanagan IR Jowsey 2005 Glutathione transferases Annu Rev Pharmacol Toxicol 45 51 88 15822171 10.1146/annurev.pharmtox.45.120403.095857 1:CAS:528:DC%2BD2MXisVWjtrk%3D Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88
28. 28. CJ Henderson CR Wolf 2011 Knockout and transgenic mice in glutathione transferase research Drug Metab Rev 43 2 152 164 21425933 10.3109/03602532.2011.562900 1:CAS:528:DC%2BC3MXkslCisLk%3D Henderson CJ, Wolf CR (2011) Knockout and transgenic mice in glutathione transferase research. Drug Metab Rev 43(2):152–164
29. 29. M Castro-Caldas A Neves Carvalho I Peixeiro E Rodrigues MC Lechner MJ Gama 2009 GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum J Mol Neurosci 38 2 114 127 18792812 10.1007/s12031-008-9141-z 1:CAS:528:DC%2BD1MXms1agt7k%3D Castro-Caldas M, Neves Carvalho A, Peixeiro I, Rodrigues E, Lechner MC, Gama MJ (2009) GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum. J Mol Neurosci 38(2):114–127
30. 30. M Castro-Caldas AN Carvalho E Rodrigues C Henderson CR Wolf MJ Gama 2012 Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway Mol Neurobiol 45 3 466 477 22539231 10.1007/s12035-012-8266-9 1:CAS:528:DC%2BC38XptVWls7w%3D Castro-Caldas M, Carvalho AN, Rodrigues E, Henderson C, Wolf CR, Gama MJ (2012) Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway. Mol Neurobiol 45(3):466–477
31. 31. V Adler Z Yin SY Fuchs M Benezra L Rosario KD Tew MR Pincus M Sardana CJ Henderson CR Wolf RJ Davis Z Ronai 1999 Regulation of JNK signaling by GSTp EMBO J 18 5 1321 1334 10064598 10.1093/emboj/18.5.1321 1:CAS:528:DyaK1MXhvFOku7g%3D Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z (1999) Regulation of JNK signaling by GSTp. EMBO J 18(5):1321–1334
32. 32. T Wang P Arifoglu Z Ronai KD Tew 2001 Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus J Biol Chem 276 24 20999 21003 11279197 10.1074/jbc.M101355200 1:CAS:528:DC%2BD3MXksFGlsLg%3D Wang T, Arifoglu P, Ronai Z, Tew KD (2001) Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276(24):20999–21003
33. 33. M Smeyne J Boyd K Raviie Shepherd Y Jiao BB Pond M Hatler R Wolf C Henderson RJ Smeyne 2007 GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism Proc Natl Acad Sci U S A 104 6 1977 1982 17267597 10.1073/pnas.0610978104 1:CAS:528:DC%2BD2sXitVejsLs%3D Smeyne M, Boyd J, Raviie Shepherd K, Jiao Y, Pond BB, Hatler M, Wolf R, Henderson C, Smeyne RJ (2007) GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism. Proc Natl Acad Sci U S A 104(6):1977–1982
34. 34. J Jahngen-Hodge MS Obin X Gong F Shang TR Nowell Jr J Gong H Abasi J Blumberg A Taylor 1997 Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress J Biol Chem 272 45 28218 28226 9353272 10.1074/jbc.272.45.28218 1:CAS:528:DyaK2sXntlCrsbc%3D Jahngen-Hodge J, Obin MS, Gong X, Shang F, Nowell TR Jr, Gong J, Abasi H, Blumberg J, Taylor A (1997) Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 272(45):28218–28226
35. 35. EJ Dudek F Shang P Valverde Q Liu M Hobbs A Taylor 2005 Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases FASEB J 19 12 1707 1709 16099947 1:CAS:528:DC%2BD2MXhtFSjsbrK Dudek EJ, Shang F, Valverde P, Liu Q, Hobbs M, Taylor A (2005) Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases. FASEB J 19(12):1707–1709
36. 36. CJ Henderson AG Smith J Ure K Brown EJ Bacon CR Wolf 1998 Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases Proc Natl Acad Sci U S A 95 9 5275 5280 9560266 10.1073/pnas.95.9.5275 1:CAS:528:DyaK1cXivV2jt7Y%3D Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR (1998) Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci U S A 95(9):5275–5280
37. 37. JH Jahngen AL Haas A Ciechanover J Blondin D Eisenhauer A Taylor 1986 The eye lens has an active ubiquitin–protein conjugation system J Biol Chem 261 29 13760 13767 3020046 1:CAS:528:DyaL28Xmt1egtLs%3D Jahngen JH, Haas AL, Ciechanover A, Blondin J, Eisenhauer D, Taylor A (1986) The eye lens has an active ubiquitin–protein conjugation system. J Biol Chem 261(29):13760–13767
38. 38. C Marques W Guo P Pereira A Taylor C Patterson PC Evans F Shang 2006 The triage of damaged proteins: degradation by the ubiquitin–proteasome pathway or repair by molecular chaperones FASEB J 20 6 741 743 16469848 1:CAS:528:DC%2BD28XjtlGqt7o%3D Marques C, Guo W, Pereira P, Taylor A, Patterson C, Evans PC, Shang F (2006) The triage of damaged proteins: degradation by the ubiquitin–proteasome pathway or repair by molecular chaperones. FASEB J 20(6):741–743
39. 39. A Hershko A Ciechanover H Heller AL Haas IA Rose 1980 Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis Proc Natl Acad Sci U S A 77 4 1783 1786 6990414 10.1073/pnas.77.4.1783 1:CAS:528:DyaL3cXlt1Oqtrk%3D Hershko A, Ciechanover A, Heller H, Haas AL, Rose IA (1980) Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis. Proc Natl Acad Sci U S A 77(4):1783–1786
40. 40. F Shang X Gong A Taylor 1997 Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated J Biol Chem 272 37 23086 23093 9287309 10.1074/jbc.272.37.23086 1:CAS:528:DyaK2sXmt1Wjtbc%3D Shang F, Gong X, Taylor A (1997) Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem 272(37):23086–23093
41. 41. X Zhang J Zhou AF Fernandes JR Sparrow P Pereira A Taylor F Shang 2008 The proteasome: a target of oxidative damage in cultured human retina pigment epithelial cells Investig Ophthalmol Vis Sci 49 8 3622 3630 10.1167/iovs.07-1559 Zhang X, Zhou J, Fernandes AF, Sparrow JR, Pereira P, Taylor A, Shang F (2008) The proteasome: a target of oxidative damage in cultured human retina pigment epithelial cells. Investig Ophthalmol Vis Sci 49(8):3622–3630
42. 42. F Shang A Taylor 1995 Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells Biochem J 307 Pt 1 297 303 7717989 1:CAS:528:DyaK2MXkvFChsrY%3D Shang F, Taylor A (1995) Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem J 307(Pt 1):297–303
43. 43. ME Figueiredo-Pereira S Yakushin G Cohen 1997 Accumulation of ubiquitinated proteins in mouse neuronal cells induced by oxidative stress Mol Biol Rep 24 1–2 35 38 9228278 10.1023/A:1006848405975 1:CAS:528:DyaK2sXks1agsrg%3D Figueiredo-Pereira ME, Yakushin S, Cohen G (1997) Accumulation of ubiquitinated proteins in mouse neuronal cells induced by oxidative stress. Mol Biol Rep 24(1–2):35–38
44. 44. AM Adamo LA Pasquini MB Moreno PI Oteiza EF Soto JM Pasquini 1999 Effect of oxidant systems on the ubiquitylation of proteins in the central nervous system J Neurosci Res 55 4 523 531 10723062 10.1002/(SICI)1097-4547(19990215)55:4<523::AID-JNR12>3.0.CO;2-Q 1:CAS:528:DyaK1MXhtlWksL8%3D Adamo AM, Pasquini LA, Moreno MB, Oteiza PI, Soto EF, Pasquini JM (1999) Effect of oxidant systems on the ubiquitylation of proteins in the central nervous system. J Neurosci Res 55(4):523–531
45. 45. KJ Davies 2001 Degradation of oxidized proteins by the 20S proteasome Biochimie 83 3–4 301 310 11295490 10.1016/S0300-9084(01)01250-0 1:CAS:528:DC%2BD3MXivFKhu7s%3D Davies KJ (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83(3–4):301–310
46. 46. T Grune K Merker G Sandig KJ Davies 2003 Selective degradation of oxidatively modified protein substrates by the proteasome Biochem Biophys Res Commun 305 3 709 718 12763051 10.1016/S0006-291X(03)00809-X 1:CAS:528:DC%2BD3sXjvFersLk%3D Grune T, Merker K, Sandig G, Davies KJ (2003) Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 305(3):709–718
47. 47. F Shang A Taylor 2011 Ubiquitin–proteasome pathway and cellular responses to oxidative stress Free Radic Biol Med 51 1 5 16 21530648 10.1016/j.freeradbiomed.2011.03.031 1:CAS:528:DC%2BC3MXntFSku7k%3D Shang F, Taylor A (2011) Ubiquitin–proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med 51(1):5–16
48. 48. M Obin F Shang X Gong G Handelman J Blumberg A Taylor 1998 Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide FASEB J 12 7 561 569 9576483 1:CAS:528:DyaK1cXivF2jtbg%3D Obin M, Shang F, Gong X, Handelman G, Blumberg J, Taylor A (1998) Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J 12(7):561–569